Last Updated on May 24, 2024 by The Health Master

NPPA

Download NPPA notification No. S.O. 1990 (E) dt 15-05-2024, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 37 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 1990(E) dt 15-04-2024 based on the decision of 123rd Authority meeting dated 10-05-2024.

The notification states as follows:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

A table is given below the article

Note:

(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules,
including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company
Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.

Table

Sl. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets	Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 1 mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s La Renon Healthcare Pvt. Ltd.	14.75
2	Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets	Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 1 mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.	14.53
3	Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets	Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 1 mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.	14.75
4	Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets	Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 2 mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s La Renon Healthcare Pvt. Ltd.	16.00
5	Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets	Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 2 mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.	16.24
6	Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets	Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 2 mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.	16.43
7	Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets	Each film coated Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 1 mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	13.35
8	Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets	Each film coated Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 2 mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	15.03
9	Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets	Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (As Extended release) Glimepiride IP 1 mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.	13.24
10	Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets	Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (As Extended release) Glimepiride IP 2 mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.	14.83

11	Diclofenac Diethylamine, Methyl Salicylate, Virgin Linseed Oil & Menthol Topical spray	Composition: Diclofenac Diethylamine IP 1.16% w/w eq. to Diclofenac Sodium 1.00% w/w, Methyl Salicylate IP 10.00% w/w, Virgin Linseed Oil BP 3.0% w/w, Menthol IP 5.00% w/w	1 gm	M/s Pontika Aerotech Limited / M/s Unison Pharmaceuticals Pvt. Ltd.	2.73
12	Povidone-Iodine & Ornidazole Ointment	Composition: Povidone-Iodine IP 5%w/w (Available Iodine 0.5%w/w) Ornidazole IP 1% w/w in an Ointment base	1 gm	M/s Curetech Skincare / M/s J.B. Chemicals & Pharmaceuticals Ltd.	4.11
13	Bisoprolol Fumarate and Telmisartan Tablets	Each film coated Tablet contains: Bisoprolol Fumarate IP 5 mg Telmisartan IP 40 mg	1 Tablet	M/s Ravenbhel Healthcare Pvt Ltd / M/s J.B. Chemicals & Pharmaceuticals Ltd.	11.21
14	Bisoprolol Fumarate and Telmisartan Tablets	Each film coated Tablet contains: Bisoprolol Fumarate IP 2.5 mg Telmisartan IP 40 mg	1 Tablet	M/s Ravenbhel Healthcare Pvt Ltd / M/s J.B. Chemicals & Pharmaceuticals Ltd.	9.65
15	Cefixime and Ofloxacin Oral suspension	Each 5ml reconstituted suspension contains: Cefixime IP as trihydrate eq. to Cefixime Anhydrous 50mg Ofloxacin IP 50mg	1 ml	M/s Innova Captab Ltd. / M/s Emcure Pharmaceuticals Ltd.	1.90
16	Ibuprofen & Paracetamol Tablets	Each uncoated Tablet contains: Ibuprofen IP 400mg Paracetamol IP 325mg	1 Tablet	M/s Prochem Pharmaceuticals Pvt. Ltd. / M/s Softdeal Pharmaceuticals Private Limited	1.59
17	Ranitidine Hydrochloride, Dicyclomine Hydrochloride & Activated Simethicone Tablet	Each film coated Tablet contains: Ranitidine Hydrochloride IP eq. to Ranitidine 150mg Dicyclomine Hydrochloride IP 10mg Activated Dimethicone IP (Simethicone) 20mg	1 Tablet	M/s IndocoRemedies Limited	2.09
18	Telmisartan, Amlodipine & Hydrochlorothia zide Tablets	Each film coated Tablet contains: Telmisartan IP 80mg, Amlodipine Besilate IP eq. to Amlodipine 5mg Hydrochlorothiazide IP 12.50mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd.	15.96
19	Telmisartan, Amlodipine & Hydrochlorothia zide Tablets	Each film coated Tablet contains: Telmisartan IP 40mg,Amlodipine Besilate IP eq. to Amlodipine 5mgHydrochlorothiazide IP 12.50mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd.	10.45
20	Ceftazidime and Avibactam (As Sodium Salt) powder for concentrate for solution for infusion	Each vial contains: Ceftazidime Pentahydrate (Sterile) eq. to Ceftazidime IP 2.0gm Avibactam Sodium (Sterile) eq. to Avibactam 0.5gm Sterile Sodium Carbonate IP (anhydrous) 232.9mg Sodium per vial content 6.44 mmol eq. to 148mg	1 Vial	M/s Aqua Vitoe Laboratories / M/s Emcure Pharmaceuticals Limited	1569.9 4

21	Glimepiride & Metformin Hydrochloride (ER) Tablets	Each uncoated bilayered Tablet contains: Glimepiride IP 4mg Metformin Hydrochloride IP 500mg (In extended-release form)	1 Tablet	M/s Innova Captab Ltd. / M/s Cadila Pharmaceuticals Ltd.	11.28
22	Glimepiride & Metformin Hydrochloride (ER) Tablets	Each uncoated bilayered Tablet contains: Glimepiride IP 3mg Metformin Hydrochloride IP 500mg (In extended release form)	1 Tablet	M/s Innova Captab Ltd. / M/s Cadila Pharmaceuticals Ltd.	9.84
23	Bilastine and Montelukast oral suspension	Each 5ml suspension contains: Bilastine 10mg Montelukast Sodium IP eq. to Monelukast 4mg	1 ml	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Sun Pharmaceuticals Industries Limited	1.72
24	Aceclofenac, Paracetamol & Thiocolchicoside Tablets	Each film coated Tablet contains: Aceclofenac IP 100mg Paracetamol IP 325mg Thiocolchicoside IP 8mg	1 Tablet	M/s Innova Captab Ltd. / M/s Mankind Pharma Ltd.	25.98
25	Aceclofenac, Paracetamol & Thiocolchicoside Tablets	Each film coated Tablet contains: Aceclofenac IP 100mg Paracetamol IP 325mg Thiocolchicoside IP 4mg	1 Tablet	M/s Innova Captab Ltd. / M/s Mankind Pharma Ltd.	18.05
26	Hydrocortisone Acetate, Lidocaine, Zinc Oxide & Allantoin Suppositories	Each suppository contains: Hydrocortisone Acetate IP 0.25% w/w Lidocaine USP 3.0% w/w Zinc Oxide IP 5.0% w/w Allantoin IP 0.5% w/w	1 Supposi tory	M/s Bliss GVS Pharma Ltd. / M/s Zydus Healthcare Limited	14.30
27	Ciprofloxacin & Tinidazole Tablet	Each film coated Tablet contains: Ciprofloxacin Hydrochloride IP eq. to Ciprofloxacin 500mg Tinidazole IP 600mg	1 Tablet	M/s Aagya Biotech Pvt. Ltd. / M/s J. B. Chemicals & Pharmaceuticals Ltd.	10.64
28	Fexofenadine Hydrochloride & Montelukast Tablet	Each film coated Tablet contains: Fexofenadine Hydrochloride IP 120mg Montelukast Sodium IP eq. to Montelukast 10mg	1 Tablet	M/s Aagya Biotech Pvt. Ltd. / M/s J. B. Chemicals & Pharmaceuticals Ltd.	15.10
29	Antacid Antigas gel	Each 10ml (two teaspoonful) contains: Dried Aluminium Hydroxide Gel IP (added as paste) 830mg Magnesium Hydroxide IP (added as paste) 185mg Sodium Carboxymethylcellulose IP 100mg Simethicone IP 50mg	1 ml	M/s Intas Pharmaceuticals Pvt. Ltd.	0.56
30	Bisoprolol Fumarate and Amlodipine Tablets	Each film coated Tablet contains: Bisoprolol Fumarate IP 2.5mg Amlodipine Besylate IP Eq. to Amlodipine 5mg	1 Tablet	M/s Savi Health Science / M/s Alkem Laboratories Ltd.	6.40

31	Bisoprolol Fumarate and Amlodipine Tablets	Each film coated Tablet contains: Bisoprolol Fumarate IP 5mg Amlodipine Besylate IP Eq. to Amlodipine 5mg	1 Tablet	M/s Savi Health Science / M/s Alkem Laboratories Ltd.	8.98
32	Atorvastatin, Clopidogrel & Aspirin Capsule	Each hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As green coloured pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two reddish brown coloured film coated Tablet, each containg 37.5mg Clopidogrel Tablets IP), Aspirin IP 75mg (As enteric coated white-coloured pellets)	1 Capsule	M/s Windlas Biotech Limited / M/s Aristo Pharmaceuticals Pvt. Ltd.	13.84
33	Levocetirizine Dihydrochloride & Montelukast Sodium suspension	Each 5ml contains: Levocetirizine Dihydrochloride IP 2.5mg Montelukast Sodium IP eq. to Montelukast 4mg	1 ml	M/s Aagya Biotech / M/s J. B. Chemicals & Pharmaceuticals Ltd.	1.47
34	Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayered Tablet contains: Linagliptin 5mg Metformin Hydrochloride IP 500mg (as extended-release form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Mankind Pharma Limited	12.86
35	Pantoprazole & Domperidone Tablet	Each gastro-resistant Tablet contains: Pantoprazole Sodium IP (as sesquihydrate) eq. to Pantoprazole 40mg Domperidone IP 10mg	1 Tablet	M/s Innova Captab Ltd. / Dr. Reddy’s Laboratories Limited	7.24
36	Chlorphenirami ne Maleate, Dextromethorph an & Phenylephrine Syrup	Each 5ml contains: Chlorpheniramine Maleate IP 2mg Phenylephrine Hydrochloride IP 5mg Dextromethorphan Hydrobromide IP 10mg	1 ml	M/s Stedman Pharmaceuticals Pvt. Ltd.	1.02
37	Cefixime and Ofloxacin Oral suspension	Each 5ml reconstituted suspension contains: Cefixime IP as trihydrate eq. to Cefixime Anhydrous 50mg Ofloxacin IP 50mg	1 ml	M/s Innova Captab Ltd. / Dr. Reddy’s Laboratories Limited	1.90

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• Fire explosion at Aurore Pharmaceuticals
  November 21, 2024
• Drug recall: Cipla recalls over 1.8k boxes of this drug
  November 21, 2024
• USFDA issued Form 483 with 7 observations to Dr Reddy’s
  November 20, 2024
• NPPA Revises Ceiling Prices of these Key Drugs
  November 20, 2024
• Approval of Anti Cancer drug Nivolumab for new Indication
  November 19, 2024
• Trump 2.0 Agenda: A Boon for Indian Pharma Industry?
  November 19, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: